Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus

Japanese Journal of Veterinary Research

Volumn 60, Issue 2-3, 2012, Pages 71-83

  Muto, Nilton Akio ^a   Yoshida, Reiko ^a   Suzuki, Tadaki ^a,b   Kobayashi, Shintaro ^a   Ozaki, Hiroichi ^c   Fujikura, Daisuke ^a   Manzoor, Rashid ^a   Muramatsu, Mieko ^a   Takada, Ayato ^a   Kimura, Takashi ^a   Sawa, Hirofumi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

HA; Influenza A virus; Inhibitory activity; M2e antibody

Indexed keywords

ANTIVIRUS AGENT; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CELL LINE; CELL STRAIN HEK293; DOG; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; PHYSIOLOGY; REVERSE GENETICS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CELL LINE; DOGS; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; REVERSE GENETICS; VIRAL MATRIX PROTEINS;

AICHI VIRUS; INFLUENZA A VIRUS;

EID: 84867183290     PISSN: 00471917     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Couch, R. B. and Kasel, J. A. 1983. Immunity to influenza in man. Annu. Rev. Microbiol., 37: 529-549.
2. Ebrahimi, S. M. and Tebianian, M. 2011. Influenza A viruses: why focusing on M2e-based universal vaccines. Virus Genes, 42: 1-8.
3. Fiers, W., De Filette, M., Birkett, A., Neirynck, S. and Min Jou, W. 2004. A "universal" human influenza A vaccine. Virus Res., 103: 173-176.
4. Gerhard, W. 2001. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol., 260: 171-190.
5. Helenius, A. 1992. Unpacking the incoming influenza virus. Cell., 69: 577-578.
6. Holsinger, L. J. and Lamb, R. A. 1991. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology, 183: 32-43.
7. Holsinger, L. J., Nichani, D., Pinto, L. H. and Lamb, R. A. 1994. Influenza A virus M2 ion channel protein: a structure-function analysis. J. Virol., 68: 1551-1563.
8. Hughey, P. G., Roberts, P. C., Holsinger, L. J., Zebedee, S. L., Lamb, R. A. and Compans, R. W. 1995. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology, 12: 411-421.
9. Ichinohe, T., Pang, I. K. and Iwasaki, A. 2010. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol., 11: 404-410.
10. Jegerlehner, A., Schmitz, N., Storni, T. and Bachmann, M. F. 2004. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibodydependent NK cell activity. J. Immunol., 172: 5598-5605.
11. Kida, H., Brown, L. E. and Webster, R. G. 1982. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/ Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology, 122: 38-47.
12. Kilbourne, E. D., Laver, W. G., Schulman, J. L. and Webster, R. G. 1968. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J. Virol., 2: 281-288.
13. Lamb, R. A., Zebedee, S. L. and Richardson, C. D. 1985. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell, 40: 627-633.
14. Mozdzanowska, K., Maiese, K., Furchner, M. and Gerhard, W. 1999. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology, 254: 138-146.
15. Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M. and Fiers, W. 1999. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med., 5: 1157-1163.
16. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., Hobom, G. and Kawaoka, Y. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA, 96: 9345-9350.
17. Pielak, R. M., Schnell, J. R. and Chou, J. J. 2009. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc. Natl. Acad. Sci. USA, 106: 7379-7384.
18. Poland, G. A., Jacobson, R. M. and Targonski, P. V. 2007. Avian and pandemic influenza: an overview. Vaccine, 25: 3057-3061.
19. Potter, C. W. and Oxford, J. S. 1979. Determinants of immunity to influenza infection in man. Br. Med. Bull., 35: 69-75.
20. Rossman, J. S., Jing, X., Leser, G. P., Balannik, V., Pinto, L. H. and Lamb, R. A. 2010. Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J. Virol., 84: 5078-5088.
21. Sasaki, M., Kim, E., Igarashi, M., Ito, K., Hasebe, R., Fukushi, H., Sawa, H. and Kimura, T. 2011. Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry. J. Biol. Chem., 286: 39370-39378.
22. Schroeder, C., Heider, H., Moncke-Buchner, E. and Lin, T. I. 2005. The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. Eur. Biophys. J., 34: 52-66.
23. Shimbo, K., Brassard, D. L., Lamb, R. A. and Pinto, L. H. 1996. Ion selectivity and activation of the M2 ion channel of influenza virus. Biophys. J., 70: 1335-1346.
24. Subbarao, K. and Joseph, T. 2007. Scientific barriers to developing vaccines against avian influenza viruses. Nat. Rev. Immunol., 7: 267-278.
25. Sugrue, R. J. and Hay, A. J. 1991. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology, 180: 617-624.
26. Sylte, M. J. and Suarez, D. L. 2009. Influenza neuraminidase as a vaccine antigen. Curr. Top. Microbiol. Immunol., 333: 227-241.
27. Takeda, M., Pekosz, A., Shuck, K., Pinto, L. H. and Lamb, R. A. 2002. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol., 76: 1391-1399.
28. Toapanta, F. R. and Ross, T. M. 2009. Impaired immune responses in the lungs of aged mice following influenza infection. Respir. Res., 10: 112.
29. Treanor, J. J., Tierney, E. L., Zebedee, S. L., Lamb, R. A. and Murphy, B. R. 1990. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J. Virol., 64: 1375-1377.
30. Zebedee, S. L. and Lamb, R. A. 1988. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol., 62: 2762-2772.